Timed inhibition of the renin-angiotensin system suppresses the rise in blood pressure upon awakening in spontaneously hypertensive rats

American Journal of Hypertension

Volumn 12, Issue 11 I, 1999, Pages 1109-1118

  Oosting, J ^a   Struijker Boudier, H A ^a   Janssen, B J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

ACE inhibitors; AT1 receptor antagonists; Captopril; Chronopharmacology; Circadian rhythms; Enalaprilat; Losartan; Pharmacodynamics

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRILAT; RENIN;

ANIMAL MODEL; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CIRCADIAN RHYTHM; CONTROLLED STUDY; DRUG EFFECT; HEMODYNAMIC PARAMETERS; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SLEEP WAKING CYCLE; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0032709843     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(99)00120-X     Document Type: Article

References (33)

1. J.E Muller G.H Tofler P.H Stone Circadian variation and triggers of onset of acute cardiovascular disease Circulation 4 1989 733 743
2. J.R Marler T.R Price G.L Clark J.E Muller T Robertson J.P Mohr D.B Hier P.A Wolf L.R Caplan M.A Foulkes Morning increases in onset of ischemic stroke Stroke 20 1989 473 476
3. B.A Gould E.B Raftery Twenty-four-hour blood pressure control an intraarterial review Chronobiol Int 8 1991 495 505
4. Materson BJ, Preston RA: Classic therapeutic trials in hypertension. Am J Hypertens 1991;4:449S–453S.
5. J.M Neutel M Alderman R.J Anders M.A Weber Novel delivery system for verapamil designed to achieve maximal blood pressure control during the early morning period Am Heart J 132 1997 1202 1206
6. P Golhke H Urbach B.A Schölknes T Unger Inhibition of converting enzyme in the cerebrospinal fluid of rats after oral treatment with converting enzyme inhibitors J Pharmacol Exp Ther 249 1989 609 616
7. B.J.A Janssen C.M Tyssen H.A.J Struyker-Boudier Modification of circadian blood pressure and heart rate variability by five different antihypertensive agents in spontaneously hypertensive rats J Cardiovasc Pharmacol 17 1991 494 503
8. B.J.A Janssen J Oosting C.M Tyssen H.A.J Struyker-Boudier Time-dependent efficacy of antihypertensive agents in spontaneously hypertensive rats Chronobiol Int 10 1993 420 434
9. D.P Veerman B.P.M Imholz W Wieling K.H Wesseling G.A Van Montfrans Circadian profile of systemic hemodynamics Hypertension 26 1995 55 59
10. Oosting J, Struijker-Boudier HAJ, Janssen BJA: Circadian and ultradian control of cardiac output in spontaneous hypertension in rats. Am J Physiol 1997;273:H66–H75.
11. J.F.M Smits H.A.J Struyker-Boudier Systemic and regional hemodynamics following acute inhibition of angiotensin I converting enzyme in the conscious spontaneously hypertensive rat Prog Pharmacol 5 1984 39 49
12. R.E Widdop S.M Gardiner P.A Kemp T Bennet Comparison of the regional haemodynamic effects of the AT1-receptor antagonists, losartan and EXP 3174, in water-deprived Brattleboro rats Br J Pharmacol 108 1993 684 688
13. A.J Voogel J.H.P Van Der Meulen G.A Van Montfrans Effects of antihypertensive drugs on the circadian blood pressure profile J Cardiovasc Pharmacol 28 1996 463 469
14. G Parati G Pomidossi F Albini D Malaspina G Mancia Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension J Hypertens 5 1987 93 98
15. Lipicky RJ: Trough:peak ratio: the rationale behind the United States Food and Drug Administration recommendations. J Hypertens 1994;12(suppl 8):s17–s19.
16. Meredith PA, Elliott HL: FDA guidelines on trough: peak ratios in the evaluation of antihypertensive agents. J Cardiovasc Pharmacol 1994;23(suppl 5):S26–S30.
17. B Lemmer K Witte T Makabe D Ganten A Mattes Effects of enalaprilat on circadian profiles in blood pressure and heart rate of spontaneously and transgenic hypertensive rats J Cardiovasc Pharmacol 23 1994 311 314
18. A Schnecko K Witte B Lemmer Effects of the angiotensin II receptor antagonist losartan on 24-hour blood pressure profiles of primary and secondary hypertensive rats J Cardiovasc Pharmacol 26 1995 214 221
19. P Gohlke T Unger Angiotensin-converting enzyme inhibitors J.D Swales Textbook of Hypertension 1994 Blackwell Scientific Publications Oxford 1115 1127
20. G.G Belz W Kirch C.H Kleinbloesem Angiotensin-converting enzyme inhibitors. Relationship between pharmacodynamics and pharmacokinetics Clin Pharmacokinet 15 1988 295 318
21. M Stepien K Witte B Lemmer Chronobiologic evaluation of angiotensin-converting enzyme activity in serum and lung tissue from normotensive and spontaneously hypertensive rats Chronobiol Int 10 1993 331 337
22. K Weisser J Schloos K Lehmann R Düsing H Vetter E Mutschler Pharmacokinetics and converting enzyme inhibition after morning and evening administration of oral enalapril to healthy subjects Eur J Clin Pharmacol 40 1991 95 99
23. K Witte K Weisser M Neubeck E Mutschler K Lehmann R Hopf B Lemmer Cardiovascular effects, pharmacokinetics, and converting enzyme inhibition of enalapril after morning versus evening administration Clin Pharmacol Ther 54 1993 177 186
24. M Hilfenhaus Circadian rhythm of the renin-angiotensin-aldosterone system in the rat Arch Toxicol 36 1976 305 316
25. J.M DeForrest J.O Davis R.H Freeman G.A Stephgens B.E Watkins Circadian changes in plasma renin activity and plasma aldosterone concentration in two-kidney hypertensive rats Hypertension 1 1979 142 149
26. R.S Modlinger K Scharif-Zadeh N.H Ertel M Gutkin The circadian rhythm of renin J Clin Endocrinol Metab 43 1976 1276 1282
27. M.J Kool J.A Wijnen F.H Derkx H.A Struijker-Boudier L.M Van-Bortel Diurnal variation in prorenin in relation to other humoral factors and hemodynamics Am J Hypertens 7 1994 723 730
28. Delp MD, Manning O, Bruckner JV, Armstrong RB: Distribution of cardiac output during diurnal changes of activity in rats. Am J Physiol 1991;261:H1487–H1493.
29. A.H Danser C.A van Kesteren W.A Bax F.H Derkx P.R Saxena M.A Schalekamp Prorenin, renin, angiotensin-converting enzyme in normal and failing human hearts. Evidence for renin binding Circulation 96 1997 220 226
30. D.H.G Smith J.M Neutel H.R Black J.A Schoenberger M.A Weber Once-daily monotherapy with trandolapril in the treatment of hypertension J Hum Hypertens 10 1996 129 134
31. P Palatini A Racioppa G Raule M Zaninotto M Penzo A.C Pessina Effect of timing of administration on the plasma ACE inhibitory activity and the antihypertensive effect of quinapril Clin Pharmacol Ther 52 1992 378 383
32. T Morgan A Anderson E Jones The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night J Hypertens 15 1997 205 211
33. P Palatini L Mos M Motolese P Mormino M Del Torre L Varotto E Pavan A.C Pessina Effect of evening versus morning benazepril on 24-hour blood pressure a comparative study with continuous intraarterial monitoring Int J Clin Pharmacol Ther Toxicol 6 1993 295 300